参考文献/References:
[1] IWAKI H,TAGAWA M,IWASAKI K,et al.Comparison of zonisamide with non-levodopa,anti-Parkinson′s disease drugs in the incidence of Parkinson′s disease-relevant symptoms[J].J Neurol Sci,2019,402:145-152.
[2] 王晔.唑尼沙胺添加治疗帕金森病[J].国际神经病学神经外科学杂志,2010,37(5):450-454.
[3] KRUPA-BURTNIK A,ZWIERZY N' SKA E,PIETRZAK B,et al.The effect of zonisamide on memory processes-A preclinical study[J].Epilepsy Behav,2020,102:106659.
[4] BIALER M,JOHANNESSEN S I,KUPFERBERG H J,et al.Prog-ress report on new antiepileptic drugs:a summary of the Fifth Eilat Conference (EILAT V) [J].Epilepsy Res,2001,43(1):11-58.
[5] 马春来,焦正,施孝金.高效液相色谱法同时测定人血浆中唑尼沙胺、苯妥英、卡马西平及环氧卡马西平的浓度[J].复旦学报(医学版),2007,34(4):603-607.
[6] 肖占琴,杨礼环,陈阳美,等.唑尼沙胺作为添加用药治疗部分性癫痫发作的有效性和安全性[J].中国医药指南,2013,11(17):487-489.
[7] PARK S P,HWANG Y H,LEE H W,et al.Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients[J].Epilepsy Behav,2008,12(1):102-108.
[8] 邢爱敏编译.抗癫痫药物唑尼沙胺易致代谢性酸中毒[J].药学进展,2009,33(5):239-240.
[9] 周燕文,梁燕,石全.唑尼沙胺片在健康志愿者体内的药动学[J].中国药杂志,2008,43(6):448-451.
[10] 中国药典委员会.中国药典2020年版第四部[M].北京:中国医药科技出版社,2020:466-471.
[11] LIU T,KOTHA R R,JONES J W,et al.Fast liquid chromatography-tandem mass spectrometry method for simultaneous determination of eight antiepileptic drugs and an active metabolite in human plasma using polarity switching and timed selected reaction monitoring[J].J Pharm Biomed Anal,2019,176:112816.
[12] 韦斯军,任斌,张志豪.高效液相色谱法测定唑尼沙胺的血药浓度[J].中国医院药学杂志,2009,29(2):132-133.
[13] 宣贵达,樊鹏利.抗癫痫药唑尼沙胺的HPLC质量分数测定法[J].浙江大学学报(理学版),2007,34(3):324-325.
相似文献/References:
[1]孙祥德,齐伟,高 革,等.反相高效液相色谱法测定人血清中氯氮平含量[J].新乡医学院学报,2001,18(03):177.
[2]李恩中,宁黔冀,李超,等.高效液相色谱法测定肝组织鸟氨酸脱羧酶活性[J].新乡医学院学报,2003,20(06):395.
[3]李恩中,宁黔冀,李超垄,等.高效液相色谱法测定肝组织鸟氨酸脱羧酶活性[J].新乡医学院学报,2003,20(06):395.